• 5X Protein Loading Buffer (Reducing): SDS-PAGE Protocol Guid

  2026-07-31

  5X Protein Loading Buffer (Reducing) provides thorough denaturation and disulfide bond reduction for SDS-PAGE, ensuring accurate protein separation by molecular weight. It is not suitable for workflows requiring preservation of native protein structure or non-reducing conditions.

• Forskolin as an Adenylate Cyclase Activator: Applied Workflo

  2026-07-30

  Forskolin is a gold-standard adenylate cyclase activator, uniquely suited for dissecting cAMP signaling and its physiological consequences in stem cell and neuroendocrine assays. This article translates cutting-edge mechanistic insights and protocol optimizations into practical, evidence-backed workflows, with troubleshooting tips tailored for advanced cellular models.

• PK/PD Evaluation of Cefazedone in Community-Acquired Pneumon

  2026-07-30

  This study provides detailed pharmacokinetic and pharmacodynamic data for intravenous cefazedone sodium in treating mild to moderate community-acquired pneumonia. The findings support a 2 g every 12 hours dosing regimen, demonstrating effective bacterial clearance and rational clinical efficacy, and inform both clinical practice and antibacterial testing workflows.

• Pioglitazone in Advanced Macrophage Polarization Assays

  2026-07-29

  Explore how Pioglitazone, a leading PPARγ agonist, enables precise macrophage polarization and inflammatory pathway research. This article uniquely details protocol considerations, mechanistic insight, and practical assay innovations for metabolic and neuroinflammatory models.

• Cefiderocol vs. β-Lactam Combinations Against Resistant Non-

  2026-07-29

  This study systematically compares the in vitro activity of cefiderocol with several β-lactam/β-lactamase inhibitor combinations against European Pseudomonas aeruginosa and Acinetobacter spp., including highly resistant isolates. The findings reveal that cefiderocol maintains high efficacy even where other therapies fail, informing antimicrobial selection in resistance research.

• DiD (DiDC 18 (5)) Probe: Precision Membrane Labeling in Infl

  2026-07-28

  Explore how DiD (DiDC 18 (5)) enables high-fidelity plasma membrane labeling in advanced inflammation and macrophage studies. This article uniquely bridges technical assay optimization with emerging insights into ROS-driven pathology.

• Levofloxacin: Mechanistic Insights and Advanced Research Uti

  2026-07-28

  Explore the molecular mechanisms and advanced experimental applications of Levofloxacin, a synthetic fluoroquinolone antibiotic. This article provides a unique, in-depth analysis for researchers optimizing assays in antibacterial and bone metabolism studies.

• Doxycycline in 3D Hydrogel Research: Mechanistic Insights fo

  2026-07-27

  Explore how Doxycycline, a tetracycline antibiotic, enables advanced study of stem cell differentiation and cancer biology within 3D hydrogel systems. This article uniquely integrates mechanotransduction insights with guidance for optimizing Doxycycline use in complex experimental models.

• 4-Hydroxytamoxifen: Technical Guidance for Experimental Work

  2026-07-27

  4-Hydroxytamoxifen (SKU B6167) is a high-purity estrogen receptor modulator optimized for DMSO-based workflows in breast cancer, prostate cancer, apoptosis, and cardiac myocyte calcium handling studies. It should not be used in protocols requiring water or ethanol solubility, and strict storage and handling are critical to ensure data reproducibility.

• Phosbind Biotin LC: Practical Guide for Phosphorylation Dete

  2026-07-26

  Phosbind Biotin LC enables sequence-independent detection of phosphorylated proteins on PVDF membranes, particularly in Western Blot workflows where phospho-specific antibodies are unavailable or inadequate. It should not be used in aqueous-only protocols or for long-term storage of working solutions.

• Enhanced A40926 Production via Engineered Nonomuraea Strain

  2026-07-25

  This study presents a dual approach to improve A40926 yields in Nonomuraea gerenzanensis by combining targeted genetic modifications with systematic medium optimization. The findings offer actionable advancements for glycopeptide antibiotic production and provide a model for integrating polygenic engineering and fermentation process design.

• Modeling P. aeruginosa Resistance to Ceftolozane via ampC/am

  2026-07-24

  This study leverages semi-mechanistic PK/PD modeling to dissect how ampC and ampD mutations in Pseudomonas aeruginosa drive resistance to ceftolozane/tazobactam during treatment. The findings clarify the individual and combined effects of these mutations, providing refined insight for resistance surveillance and translational antibacterial research.

• Cisplatin in Translational Oncology: Mechanisms, Models, and

  2026-07-24

  This thought-leadership article unpacks the mechanistic underpinnings and translational guidance for deploying Cisplatin (CDDP) in cancer research. Drawing on recent insights into DNA crosslinking, apoptosis, and immune escape via ER stress proteins like GRP78, it provides actionable strategies for researchers navigating the evolving landscape of chemoresistance and immunomodulation. The discussion is anchored by APExBIO's Cisplatin (A8321), integrating best practices, evidence-based benchmarking, and a forward-looking perspective for maximizing clinical relevance.

• Pyridostatin TFA: G-Quadruplex Stabilizer for Cancer and Neu

  2026-07-23

  Pyridostatin TFA is a synthetic G-quadruplex DNA structure stabilizer used in telomere biology and cancer cell growth inhibition. It selectively binds G-quadruplexes, disrupts telomere function, and shows preferential cytotoxicity in cancer versus normal cells. Its robust solubility and reproducibility make it a reference tool for DNA secondary structure research.

• SB 203580: Strategic Inhibition of p38 MAPK in Translational

  2026-07-23

  Explore how SB 203580 enables precise modulation of the p38 MAPK pathway, with a focus on orofacial neuropathic pain mechanisms. This thought-leadership article bridges mechanistic insight with practical strategy for translational researchers, integrating recent findings on ROS–p38 MAPK signaling and offering actionable protocol guidance.

414 records 7/28 page Previous Next First page 上5页 678910 下5页 Last page